Latest news
Replimune’s First Commercial Drug Arrives—With A 2027 Cash Cliff And 2030 Finish Line - StocktwitsStocktwits · Sat, 08 Aug 2026 00:59:00 GMTREPL Stock Clocks Worst Day In Over 3 Months — New FDA Documents Leave Wall Street Awaiting Another Rejection For Cancer Drug - StocktwitsStocktwits · Fri, 07 Aug 2026 21:27:03 GMTSOFI Stock Rises Overnight: Company Announces New Multi-Year Partnership With Notre Dame Athletics Ahead Of Q2 Results - StocktwitsStocktwits · Fri, 07 Aug 2026 15:46:43 GMTMRNA Stock Clocks Best Day In Over Two Months On Early-Stage Hantavirus Vaccine Research - StocktwitsStocktwits · Fri, 07 Aug 2026 07:24:59 GMTREPL Stock Slumps 11% After-Hours — What’s Driving The Selloff? - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 21:37:21 GMTNVDA Rival Cerebras Plans To List On Thursday Next Week: Report - StocktwitsStocktwits · Wed, 05 Aug 2026 20:58:25 GMTREPL Stock Tracks Best Day Ever: This Analyst Sees Higher Approval Odds For Replimune’s Melanoma After ‘Overwhelmingly Positive’ Panel Outcome - StocktwitsStocktwits · Fri, 31 Jul 2026 10:48:25 GMTTop Midday Gainers - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMT